Investors

Below are the projects for witch a co-development can be discussed:

•  GBT013: A collagen based skin substitute for chronic wounds

  -          Advantages of the product include i) faster healing time, ii) better tissue healing quality and iii) a very few number of dressing used. This product has already a CE mark.

-          Co-development will consist in a phase III superiority clinical trial.

•  GBT021 : Patented micro-technology for wrinkle filling.

   

If your company is seeking for projects in co-development, we will be happy to give you more information after sending you a NDA to be signed.